Search using our robust engine. Get the recommendations you need to get ahead.
Browse through our expansive list of legal practice areas.
Work where you are or where you would like to be. Find where you will work with LawCrossing.
Use our marketplace to feature your opportunity
Start your search today
Set up your account and manage your company profile on LawCrossing
Look through and compare company profiles
Learn from the legal expert
Discover salaries and the scope of your next job
LawCrossing Works Read Testimonials and Share your Story
The Inner Voices, Arnold Schwarzenegger, and Your Life
Headline: Sorrento Therapeutics, Inc.: Pioneering Multimodal Cancer Therapies for a Brighter Future
Sorrento Therapeutics, Inc. (Nasdaq: SRNE) is a clinical-stage biopharmaceutical company that is revolutionizing cancer treatment. With a focus on developing innovative therapies to transform malignant cancers into manageable and potentially curable diseases, Sorrento Therapeutics is at the forefront of the fight against cancer. By adopting a multimodal multipronged approach, the company aims to target cancer cells from various angles, providing hope for patients and offering exciting opportunities for its employees.
Sorrento Therapeutics recognizes that cancers are genetically diverse, highly adaptive, constantly mutating, and virtually invisible to the immune system. This understanding has shaped the company's approach to cancer therapy. Rather than relying on single-target therapies that have shown limited success, Sorrento Therapeutics believes in attacking cancer on multiple fronts simultaneously or sequentially. By targeting a single or diverse set of cellular targets, the company aims to relentlessly combat cancer and improve patient outcomes.
Sorrento Therapeutics' commitment to innovation and patient care sets it apart in the biopharmaceutical industry. The company's research and development efforts are focused on developing antibody-centric therapies that have the potential to revolutionize cancer treatment. Through its extensive pipeline of novel drugs, Sorrento Therapeutics aims to address the unmet medical needs of cancer patients and provide hope for a brighter future.
One of the key areas of focus for Sorrento Therapeutics is the development of antibody-drug conjugates (ADCs). These ADCs combine the targeting ability of antibodies with the potent cytotoxic effects of chemotherapy drugs. By delivering the chemotherapy directly to cancer cells, ADCs minimize the damage to healthy cells, reducing side effects and improving patient quality of life. This cutting-edge technology has the potential to transform the way cancer is treated.
In addition to ADCs, Sorrento Therapeutics is also exploring other innovative approaches to cancer therapy. The company's portfolio includes chimeric antigen receptor T-cell (CAR-T) therapies, which harness the power of the immune system to target and destroy cancer cells. By engineering patients' own T-cells to express CARs, Sorrento Therapeutics is paving the way for personalized cancer treatments that can effectively combat even the most challenging malignancies.
Working at Sorrento Therapeutics offers employees the opportunity to be part of a dynamic and innovative team that is making a real difference in the fight against cancer. The company's commitment to developing groundbreaking therapies means that employees are at the forefront of scientific advancements and have the chance to contribute to cutting-edge research.
Sorrento Therapeutics fosters a collaborative and inclusive work environment, where employees are encouraged to share their ideas and expertise. The company values diversity and believes that a diverse workforce leads to better innovation and problem-solving. Employees are empowered to take ownership of their work and are provided with the resources and support needed to excel in their roles.
Furthermore, Sorrento Therapeutics recognizes the importance of work-life balance and offers competitive compensation packages, including comprehensive health benefits and retirement plans. The company also provides opportunities for professional development and growth, with ongoing training programs and mentorship opportunities.
Sorrento Therapeutics, Inc. is a pioneering biopharmaceutical company that is revolutionizing cancer treatment through its innovative approach to therapy. By targeting cancer cells from multiple angles, Sorrento Therapeutics aims to transform malignant cancers into manageable and possibly curable diseases. Working at Sorrento Therapeutics offers employees the opportunity to be part of a dynamic and innovative team, contributing to cutting-edge research and making a real difference in the lives of cancer patients. With a collaborative work environment, competitive compensation packages, and a commitment to employee growth, Sorrento Therapeutics is an exciting place to work for those passionate about advancing cancer treatment.